Clinical Trials Directory

Trials / Completed

CompletedNCT02848378

Advanced Oxidation Protein Product and Monocyte Chemoattractant Protein-1 in Periodontal Disease

The Levels of Advanced Oxidation Protein Product and Monocyte Chemoattractant Protein-1 in Gingival Crevicular Fluid in Periodontal Disease and Health

Status
Completed
Phase
Study type
Observational
Enrollment
75 (actual)
Sponsor
Kırıkkale University · Academic / Other
Sex
All
Age
18 Years – 66 Years
Healthy volunteers
Accepted

Summary

This study investigates the levels of advanced oxidation protein product and monocyte chemoattractant protein-1 in gingival crevicular fluid in periodontal disease and health. 25 participants with chronic periodontitis, 25 participants with gingivitis and 25 periodontally healthy subjects are included into this study. In each participant, four sites are identified for gingival crevicular fluid samples.

Detailed description

Oxidative stress is the disequilibrium between the formation of free radicals and antioxidant defense mechanisms via damaging cellular macromolecules (DNA, protein, lipid, etc..) which are susceptible to oxidative damage. Advanced oxidation protein product is identified as a new marker of protein oxidation. Monocyte chemoattractant protein-1 is a major chemoattractant for lymphocytes, monocytes and macrophages.

Conditions

Timeline

Start date
2014-05-01
Primary completion
2015-01-01
Completion
2015-04-01
First posted
2016-07-28
Last updated
2016-07-28

Source: ClinicalTrials.gov record NCT02848378. Inclusion in this directory is not an endorsement.